BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10334013)

  • 1. Postural compensation after intratympanic gentamicin treatment of Menière's disease.
    Pyykkö I; Eklund S; Ishizaki H; Aalto H
    J Vestib Res; 1999; 9(1):19-26. PubMed ID: 10334013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VEMPs and dynamic posturography after intratympanic gentamycin in Menière's disease.
    Picciotti PM; Fiorita A; Di Nardo W; Quaranta N; Paludetti G; Maurizi M
    J Vestib Res; 2005; 15(3):161-8. PubMed ID: 16179764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratympanic gentamicin in bilateral Menière's disease.
    Pyykkö I; Ishizaki H; Kaasinen S; Aalto H
    Otolaryngol Head Neck Surg; 1994 Feb; 110(2):162-7. PubMed ID: 8108151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
    Wu IC; Minor LB
    Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratympanic gentamicin for intractable Meniere's disease.
    Perez N; Martín E; García-Tapia R
    Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratympanic gentamicin injection for the treatment of Meniere's disease.
    Youssef TF; Poe DS
    Am J Otol; 1998 Jul; 19(4):435-42. PubMed ID: 9661751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intratympanic gentamicin treatment for intractable Menière's disease].
    Gilony D; Wolf M; Kronenberg J
    Harefuah; 2004 Jan; 143(1):4-7, 88. PubMed ID: 14748278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term disability of class A patients with Ménière's disease after treatment with intratympanic gentamicin.
    Boleas-Aguirre MS; Sánchez-Ferrandiz N; Guillén-Grima F; Perez N
    Laryngoscope; 2007 Aug; 117(8):1474-81. PubMed ID: 17607149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors relating to the vertigo control and hearing changes following intratympanic gentamicin for intractable Ménière's disease.
    Horii A; Saika T; Uno A; Nishiike S; Mitani K; Nishimura M; Kitahara T; Fukushima M; Nakagawa A; Masumura C; Sasaki T; Kizawa K; Kubo T
    Otol Neurotol; 2006 Sep; 27(6):896-900. PubMed ID: 16788414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Ménière's disease by low-dosage intratympanic gentamicin application: effect on otolith function.
    Helling K; Schönfeld U; Clarke AH
    Laryngoscope; 2007 Dec; 117(12):2244-50. PubMed ID: 17909448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term results after interval therapy with intratympanic gentamicin for Menière's disease.
    Lange G; Maurer J; Mann W
    Laryngoscope; 2004 Jan; 114(1):102-5. PubMed ID: 14710003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratympanic gentamicin treatment in Meniere's disease: patients' experiences and outcomes.
    Smith WK; Sandooram D; Prinsley PR
    J Laryngol Otol; 2006 Sep; 120(9):730-5. PubMed ID: 16848921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexamethasone inner ear perfusion by intratympanic injection in unilateral Ménière's disease: a two-year prospective, placebo-controlled, double-blind, randomized trial.
    Garduño-Anaya MA; Couthino De Toledo H; Hinojosa-González R; Pane-Pianese C; Ríos-Castañeda LC
    Otolaryngol Head Neck Surg; 2005 Aug; 133(2):285-94. PubMed ID: 16087029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oculomotor findings mimicking a cerebellar disorder and postural control in severe Meniere's disease.
    Isotalo E; Heikki A; Ilmari P
    Auris Nasus Larynx; 2009 Feb; 36(1):36-41. PubMed ID: 18501541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transtympanic gentamicin and fibrin tissue adhesive for treatment of unilateral Menière's disease: effects on vestibular function.
    Casani A; Nuti D; Franceschini SS; Gaudini E; Dallan I
    Otolaryngol Head Neck Surg; 2005 Dec; 133(6):929-35. PubMed ID: 16360516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratympanic gentamicin therapy for intractable Ménière's disease.
    De Beer L; Stokroos R; Kingma H
    Acta Otolaryngol; 2007 Jun; 127(6):605-12. PubMed ID: 17503229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratympanic gentamicin for Menière's disease: a meta-analysis.
    Cohen-Kerem R; Kisilevsky V; Einarson TR; Kozer E; Koren G; Rutka JA
    Laryngoscope; 2004 Dec; 114(12):2085-91. PubMed ID: 15564826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Auditory results after vestibular nerve section and intratympanic gentamicin for Ménière's disease.
    Colletti V; Carner M; Colletti L
    Otol Neurotol; 2007 Feb; 28(2):145-51. PubMed ID: 17255880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hearing results following intratympanic gentamicin perfusion for Ménière's disease.
    Kyrodimos E; Aidonis I; Sismanis A
    J Laryngol Otol; 2009 Apr; 123(4):379-82. PubMed ID: 18954493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intratympanic gentamicin in Meniere's disease.
    Kaasinen S; Pyykkö I; Ishizaki H; Aalto H
    Acta Otolaryngol; 1998 Jun; 118(3):294-8. PubMed ID: 9655201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.